GPR65 and Hepatic fibrosis: The hepatic hydroxyproline content in BDL-treated GPR65-KO mice was also markedly decreased compared to BDL-treated WT mice (Additional file 1: Fig. S3g), suggesting that loss of Gpr65 significantly alleviated BDL-induced hepatic fibrosis.